Europe - Euronext Oslo - OSL:VISTN - NO0010734122 - Common Stock
Taking everything into account, VISTN scores 5 out of 10 in our fundamental rating. VISTN was compared to 55 industry peers in the Pharmaceuticals industry. VISTN is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. VISTN is valued correctly, but it does not seem to be growing.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.36% | ||
| ROE | 24.96% | ||
| ROIC | 20.45% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 20.82% | ||
| PM (TTM) | 17.16% | ||
| GM | 66.4% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.07 | ||
| Debt/FCF | 0.32 | ||
| Altman-Z | 7.7 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.23 | ||
| Quick Ratio | 1.16 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.88 | ||
| Fwd PE | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 14.28 | ||
| EV/EBITDA | 7.94 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.1% |
ChartMill assigns a fundamental rating of 5 / 10 to VISTN.OL.
ChartMill assigns a valuation rating of 4 / 10 to VISTIN PHARMA ASA (VISTN.OL). This can be considered as Fairly Valued.
VISTIN PHARMA ASA (VISTN.OL) has a profitability rating of 5 / 10.
The financial health rating of VISTIN PHARMA ASA (VISTN.OL) is 8 / 10.
The dividend rating of VISTIN PHARMA ASA (VISTN.OL) is 5 / 10 and the dividend payout ratio is 99.41%.